Fountain Therapeutics is a biopharmaceutical company building a pipeline of therapeutics to treat age-related diseases by reversing cellular age. The company's cell-based AI-driven technology platform, fueled by the expertise of leaders in aging research and computation, extracts previously hidden cellular features that provide unprecedented and extensive insights into the aging process of cells. Fountain has united science, medicine and engineering to turn these insights and technology into a powerful drug discovery and development engine that introduces a new avenue to advance therapies for age-related health conditions.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/21/20 | $6,000,000 | Series A-1 |
Nan Fung | undisclosed |
